Trevi Therapeutics Inc (TRVI)

R&D Expenses

$15.15M

Quarterly · Period ending: · USD

TRVI logo

TRVI R&D Expenses

Latest reported$15.15M
TRVI Quarterly R&D Expenses ($1.60M → $15.15M)
High-resolution chart · PNG

TRVI r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
15,152,000
9,941,000
6,193,000
10,085,000
9,389,000
7,811,000
9,328,000
11,224,000
10,021,000
8,804,000
6,518,000
6,323,000
5,842,000
5,000,000
4,317,000
5,769,000
5,103,000
4,645,000
6,179,000
4,718,000
6,498,000
5,589,000
6,560,000
4,828,000
4,921,000
6,019,000
4,823,000
5,650,000
5,528,000
3,338,000
4,523,000
3,747,000
3,439,000
2,363,000
1,598,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.